[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334640-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334640-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-state-of-the-art-mechanisms-and-antitumor-effects-of-somatostatin-in-colorectal-cancer-a-review","The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer - A Review","","Somatostatin (SST, SRIF) is a widely distributed cyclic peptide that signals through transmembrane G protein-coupled receptors (SST1-SST5). Research over recent decades has clarified how this hormonal peptide and its synthetic analogues exert antitumor activity, with the strongest evidence in gastroenteropancreatic neuroendocrine tumors and emerging data for colorectal cancer (CRC). In CRC, SST-driven antitumor signaling mainly involves MAPK/ERK/AKT and Wnt/β-catenin, including direct and indirect antiangiogenic and anti-inflammatory roles, though mechanisms and tumor microenvironment–microbiome interactions remain incompletely defined. The review synthesizes current mechanisms and antitumor activity, emphasizing sporadic CRC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-state-of-the-art-mechanisms-and-antitumor-effects-of-somatostatin-in-colorectal-cancer-a-review/334640/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-state-of-the-art-mechanisms-and-antitumor-effects-of-somatostatin-in-colorectal-cancer-a-review/334640.png","ImageObject",300,407,{"name":42,"@type":43},"Lucas Martin","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What receptors mediate somatostatin’s action in cancer biology?","Question",{"text":63,"@type":64},"Somatostatin signals through five somatostatin receptor types: SST1, SST2, SST3, SST4, and SST5. These receptors belong to the transmembrane G protein-coupled receptor family.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which signaling pathways are mainly involved in somatostatin’s antitumor function in colorectal cancer?",{"text":68,"@type":64},"The antitumor signaling pathways highlighted for colorectal cancer primarily include MAPK/ERK/AKT and Wnt/β-catenin.",{"name":70,"@type":61,"acceptedAnswer":71},"How does somatostatin influence angiogenesis and inflammation in colorectal cancer?",{"text":72,"@type":64},"The review describes direct and indirect antiangiogenic effects, including VEGF-related mechanisms. It also emphasizes an anti-inflammatory role, while noting that detailed molecular mechanisms are still being investigated.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334640,1790073603,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","biomedicines  \nReview  \nThe State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review  \nAldona Kasprzak * and Agnieszka Geltz  \nCitation: Kasprzak, A.; Geltz, A. The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review.  \nBiomedicines 2024, 12, 578 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biomedicines12030578  \nAcademic Editor: Christos K. Kontos  \nReceived: 28 January 2024  \nRevised: 2 March 2024  \nAccepted: 3 March 2024  \nPublished: 5 March 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nDepartment of Histology and Embryology, University of Medical Sciences, Swiecicki Street 6, 60-781 Pozna ´n, Poland; [szumigala.agnieszka@gmail.com](szumigala.agnieszka@gmail.com)  \n* Correspondence: [akasprza@ump.edu.pl](akasprza@ump.edu.pl); Tel.: +48-61-8546441; Fax: +48-61-8546440  \nAbstract: Somatostatin, a somatotropin release inhibiting factor (SST, SRIF), is a widely distributed multifunctional cyclic peptide and acts through a transmembrane G protein-coupled receptor (SST1-SST5) . Over the past decades, research has begun to reveal the molecular mechanisms underlying the anticancer activity of this hormonal peptide. Among gastrointestinal tract (GIT) tumors, direct and indirect antitumor effects of SST have been documented best in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) and less well in non-endocrine cancers, including sporadic colorectal cancer (CRC) . In the latter, the signaling pathways involved in the antitumor function of SST are primarily MAPK/ERK/AKT and Wnt/β–catenin. Direct (involving the MAPK pathway)  \nand indirect (VEGF production) antiangiogenic effects of SST in CRC have also been described. The anti-inflammatory role of SST in CRC is emphasized, but detailed molecular mechanisms are still being explored. The role of SST in tumor genome/tumor microenvironment (TME)/host’s gut microbiome interactions is only partially known. The results of SST analogues (SSAs)’ treatment of sporadic CRC in monotherapy in vivo are not spectacular. The current review aims to present the state-of-the-art mechanisms and antitumor activity of endogenous SST and its synthetic analogues in CRC, with particular emphasis on sporadic CRC.  \nKeywords: neuroendocrine and non-endocrine tumors; colorectal cancer (CRC); somatostatin (SST, SRIF); somatostatin analogues (SSAs); mechanisms of antitumor activity; SST/SSAs in cancer therapy  \n1. Introduction  \nColorectal cancer (CRC), which encompasses the colorectum (including the anus), referred to as ICD-10 C18-C21 [1], is the third most prevalent malignant tumor around the world (including Europe) and second among cancer-related death causes [2–4] . In Poland in 2020, in terms of incidence, it also ranked third among both sexes. As a cause of mortality, it was in second place in men and third in women [3] . About 90% of CRC cases are sporadic, caused by somatic mutations leading to invasive cancer [5] .  \nAntitumor effects include primarily inhibiting cell proliferation and increasing cell apoptosis. Other processes (often associated with antiproliferative effects) include inhibition of angiogenesis and regulation of the tumor’s immune status [6,7] . In the case of CRC, potential antitumor effects also include eliminating chronic inflammatory changes, modifying the intestinal microbiome and regulating the intestinal barrier and the interaction between cancer and the tumor microenvironment (TME) [8–12] . Somatostatin, asomatotropin release inhibiting factor (SST, SRIF), discovered in the rat/ovine hypothalamus [13,14], is a widely distributed multifun","cbCairzzkhOUvbq3","https://ap.wps.com/l/cbCairzzkhOUvbq3","pdf",3244143,48,"English","# Introduction\n## Colorectal cancer burden and sporadic etiology\n## Antitumor effects and relevance to CRC\n## Somatostatin and its receptor-mediated signaling\n# Key antitumor mechanisms through SST receptors\n## Adenylyl cyclase inhibition and cAMP downregulation\n## Protein tyrosine phosphatase activation and MAPK suppression\n## PI3K/AKT signaling and cell-cycle regulation\n## Calcium signaling pathways","[{\"question\":\"What receptors mediate somatostatin’s action in cancer biology?\",\"answer\":\"Somatostatin signals through five somatostatin receptor types: SST1, SST2, SST3, SST4, and SST5. These receptors belong to the transmembrane G protein-coupled receptor family.\"},{\"question\":\"Which signaling pathways are mainly involved in somatostatin’s antitumor function in colorectal cancer?\",\"answer\":\"The antitumor signaling pathways highlighted for colorectal cancer primarily include MAPK/ERK/AKT and Wnt/β-catenin.\"},{\"question\":\"How does somatostatin influence angiogenesis and inflammation in colorectal cancer?\",\"answer\":\"The review describes direct and indirect antiangiogenic effects, including VEGF-related mechanisms. It also emphasizes an anti-inflammatory role, while noting that detailed molecular mechanisms are still being investigated.\"}]","The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer - A Review | PDF",1790007615,121]